checkAd
    Startseite > Aktien > Agios Pharmaceuticals > Nachrichten
    Agios Pharmaceuticals Aktie
    33,00
     
    USD
    +0,24 %
    +0,08 USD
    Letzter Kurs 11.05.24 Nasdaq
    33,01
     
    USD
    300 STK
    Geldkurs 10.05.24
    33,04
     
    USD
    600 STK
    Briefkurs 10.05.24
    ISIN: US00847X1046 · WKN: A1W2RM · SYM: AGIO · USA

    Neueste Nachrichten

    Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024
    06.05.24 · globenewswire · Agios Pharmaceuticals
    Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
    03.05.24 · globenewswire · Agios Pharmaceuticals
    Agios Reports Business Highlights and First Quarter 2024 Financial Results
    02.05.24 · globenewswire · Agios Pharmaceuticals
    Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
    18.04.24 · globenewswire · Agios Pharmaceuticals
    Agios Publishes 2024 Environmental, Social and Governance (ESG) Report
    09.04.24 · globenewswire · Agios Pharmaceuticals
    Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024
    05.03.24 · globenewswire · Agios Pharmaceuticals
    Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024
    22.02.24 · globenewswire · Agios Pharmaceuticals
    Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
    15.02.24 · globenewswire · Agios Pharmaceuticals
    Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024
    02.02.24 · globenewswire · Agios Pharmaceuticals
    Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
    08.01.24 · globenewswire · Agios Pharmaceuticals
    Agios Announces Phase 3 ENERGIZE Study of Mitapivat Met Primary Endpoint and Both Key Secondary Endpoints in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia
    03.01.24 · globenewswire · Agios Pharmaceuticals
    Agios to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024
    02.01.24 · globenewswire · Agios Pharmaceuticals